OCX logo

OncoCyte (OCX) Operating Profit

Annual Operating Profit

-$22.42 M
+$6.43 M+22.30%

December 31, 2023

Summary

Performance

1-Year Change

+22.3%

3-Year Change

+33.52%

5-Year Change

-47.46%

15-Year Change

-18.93%

OCX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.56%
OCX annual operating income is higher than 51.56% of companies in Healthcare sector

High & Low

All-time High

-$3.50 M

3-Year Low

-$28.85 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OCX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 11, 2025
OCX next annual earnings announcement is scheduled for Apr 11, 2025

OtherOCXprofitabilitymetrics:

Annual Operating Margin

-1491.48%
OCX annual operating profit margin is -1491.48%

Annual Revenue

$1.50 M
OCX annual revenue is $1.50 million

Annual Net Income

-$27.78 M
OCX annual net profit is -$27.78 million

Annual EPS

-$3.75
OCX annual earnings per share is -$3.75

Quarterly Operating Profit

-$6.38 M
-$712.00 K-12.57%

September 30, 2024

Summary

Performance

3-Month Change

-12.57%

1-Year Change

-24.51%

3-Year Change

+18.9%

5-Year Change

+18.9%

OCX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.21%
OCX quarterly operating income is higher than 46.21% of companies in Healthcare sector

High & Low

All-time High

$9.81 M
OCX quarterly operating income is currently -164.96% below its historical high of $9.81 million

3-Year Low

-$7.86 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OCX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 11, 2025
OCX next earnings announcement is scheduled for Apr 11, 2025

OtherOCXprofitabilitymetrics:

Quarterly Operating Margin

-5543.48%
OCX quarterly operating profit margin is -5543.48%

Quarterly Revenue

$115.00 K
OCX quarterly revenue is $115.00 thousand

Quarterly Net Income

-$13.49 M
OCX quarterly net profit is -$13.49 million

Quarterly EPS

-$0.98
OCX quarterly earnings per share is -$0.98

TTM Operating Profit

-$22.88 M
-$1.25 M-5.80%

September 30, 2024

Summary

Performance

3-Month Change

-5.8%

1-Year Change

+2.18%

3-Year Change

-26.02%

5-Year Change

-26.02%

OCX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.25%
OCX TTM operating income is higher than 50.25% of companies in Healthcare sector

High & Low

All-time High

-$1.50 M

3-Year Low

-$28.85 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OCX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 11, 2025
OCX next earnings announcement is scheduled for Apr 11, 2025

OtherOCXprofitabilitymetrics:

Annual Operating Margin

-1491.48%
OCX annual operating profit margin is -1491.48%

TTM Revenue

$709.00 K
OCX TTM revenue is $709.00 thousand

TTM Net Income

-$43.14 M
OCX TTM net profit is -$43.14 million

TTM EPS

-$4.54
OCX TTM earnings per share is -$4.54

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$22.42 M
OCX annual operating income is -$22.42 million

Annual Gross Profit

$413.00 K
OCX annual gross profit is $413.00 thousand

Annual Operating Expenses

$22.83 M
OCX annual total operating expenses is $22.83 million

OCX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+22.3%-24.5%+2.2%
3 y3 years+33.5%+18.9%-26.0%
5 y5 years-47.5%+18.9%-26.0%

OCX Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+22.3%-165.0%+18.9%-75.8%+20.7%
5 y5-year-0.8%+33.5%-165.0%+48.7%-75.8%+44.5%
alltimeall time-541.4%+33.5%-165.0%+48.7%-1427.3%+44.5%

OncoCyte Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$6.38 M(+12.6%)
-$22.88 M(+5.8%)
Jun 2024
-
-$5.66 M(-2.1%)
-$21.62 M(-1.6%)
Mar 2024
-
-$5.79 M(+14.5%)
-$21.98 M(-2.0%)
Dec 2023
-$22.42 M(-22.3%)
-$5.05 M(-1.3%)
-$22.42 M(-4.2%)
Sep 2023
-
-$5.12 M(-14.9%)
-$23.39 M(-8.5%)
Jun 2023
-
-$6.02 M(-3.3%)
-$25.56 M(-6.7%)
Mar 2023
-
-$6.22 M(+3.3%)
-$27.40 M(-5.0%)
Dec 2022
-$28.85 M(+20.2%)
-$6.03 M(-17.3%)
-$28.85 M(+121.8%)
Sep 2022
-
-$7.29 M(-7.3%)
-$13.01 M(-28.3%)
Jun 2022
-
-$7.86 M(+2.5%)
-$18.16 M(-15.6%)
Mar 2022
-
-$7.67 M(-178.2%)
-$21.51 M(-10.9%)
Dec 2021
-$24.01 M(-28.8%)
$9.81 M(-178.9%)
-$24.14 M(-41.5%)
Sep 2021
-
-$12.43 M(+10.9%)
-$41.25 M(+8.4%)
Jun 2021
-
-$11.21 M(+8.9%)
-$38.04 M(+6.9%)
Mar 2021
-
-$10.30 M(+41.2%)
-$35.59 M(+5.5%)
Dec 2020
-$33.72 M(+51.6%)
-$7.30 M(-20.9%)
-$33.72 M(-0.7%)
Sep 2020
-
-$9.22 M(+5.2%)
-$33.95 M(+13.2%)
Jun 2020
-
-$8.77 M(+4.0%)
-$29.98 M(+12.4%)
Mar 2020
-
-$8.43 M(+12.1%)
-$26.67 M(+19.9%)
Dec 2019
-$22.24 M
-$7.52 M(+43.1%)
-$22.24 M(+18.5%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$5.26 M(-3.8%)
-$18.76 M(+13.5%)
Jun 2019
-
-$5.46 M(+36.7%)
-$16.53 M(+8.1%)
Mar 2019
-
-$4.00 M(-1.2%)
-$15.29 M(+0.6%)
Dec 2018
-$15.20 M(-19.3%)
-$4.05 M(+33.9%)
-$15.20 M(+1.0%)
Sep 2018
-
-$3.02 M(-28.5%)
-$15.05 M(-20.2%)
Jun 2018
-
-$4.23 M(+8.2%)
-$18.86 M(+3.5%)
Mar 2018
-
-$3.91 M(+0.4%)
-$18.22 M(-3.3%)
Dec 2017
-$18.85 M(+69.2%)
-$3.89 M(-43.1%)
-$18.85 M(+4.4%)
Sep 2017
-
-$6.83 M(+90.4%)
-$18.05 M(+30.8%)
Jun 2017
-
-$3.59 M(-20.8%)
-$13.80 M(+8.3%)
Mar 2017
-
-$4.53 M(+46.5%)
-$12.74 M(+14.4%)
Dec 2016
-$11.14 M(+27.8%)
-$3.09 M(+19.8%)
-$11.14 M(-3.8%)
Sep 2016
-
-$2.58 M(+2.0%)
-$11.59 M(+1.5%)
Jun 2016
-
-$2.53 M(-13.6%)
-$11.41 M(+11.0%)
Mar 2016
-
-$2.93 M(-17.2%)
-$10.28 M(+18.0%)
Dec 2015
-$8.72 M(+75.3%)
-$3.54 M(+47.1%)
-$8.72 M(+30.6%)
Sep 2015
-
-$2.41 M(+71.2%)
-$6.68 M(+56.3%)
Jun 2015
-
-$1.41 M(+2.8%)
-$4.27 M(+49.0%)
Mar 2015
-
-$1.37 M(-8.7%)
-$2.87 M(+91.3%)
Dec 2014
-$4.97 M(+42.3%)
-$1.50 M
-$1.50 M
Dec 2013
-$3.50 M
-
-

FAQ

  • What is OncoCyte annual operating income?
  • What is the all time high annual operating profit for OncoCyte?
  • What is OncoCyte annual operating profit year-on-year change?
  • What is OncoCyte quarterly operating income?
  • What is the all time high quarterly operating profit for OncoCyte?
  • What is OncoCyte quarterly operating profit year-on-year change?
  • What is OncoCyte TTM operating income?
  • What is the all time high TTM operating profit for OncoCyte?
  • What is OncoCyte TTM operating profit year-on-year change?

What is OncoCyte annual operating income?

The current annual operating profit of OCX is -$22.42 M

What is the all time high annual operating profit for OncoCyte?

OncoCyte all-time high annual operating income is -$3.50 M

What is OncoCyte annual operating profit year-on-year change?

Over the past year, OCX annual operating income has changed by +$6.43 M (+22.30%)

What is OncoCyte quarterly operating income?

The current quarterly operating profit of OCX is -$6.38 M

What is the all time high quarterly operating profit for OncoCyte?

OncoCyte all-time high quarterly operating income is $9.81 M

What is OncoCyte quarterly operating profit year-on-year change?

Over the past year, OCX quarterly operating income has changed by -$1.25 M (-24.51%)

What is OncoCyte TTM operating income?

The current TTM operating profit of OCX is -$22.88 M

What is the all time high TTM operating profit for OncoCyte?

OncoCyte all-time high TTM operating income is -$1.50 M

What is OncoCyte TTM operating profit year-on-year change?

Over the past year, OCX TTM operating income has changed by +$511.00 K (+2.18%)